Inflammation-Related Gene Signature: An Individualized Risk Prediction Model for Kidney Renal Clear Cell Carcinoma

Figure 7

Validation of the prognostic signature based on nine inflammation-related genes in different cohorts. (a–e) Survival assays of the 9-IFRG prognostic signature in the testing-1 cohort, testing-2 cohort, testing-3 cohort, testing-4 cohort, and the entire group, respectively. (f–j) Time-dependent ROC curves of the 9-IFRG prognostic risk signature in the four cohorts.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)